Načítá se...
Ceftolozane–tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study
OBJECTIVES: Published in vitro stability data for ceftolozane–tazobactam supports intermittent short duration infusions. This method of delivery is not feasible for many outpatient antimicrobial therapy services that provide only one or two visits per day. This study aimed to assess time, temperatur...
Uloženo v:
| Vydáno v: | Eur J Hosp Pharm |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7147556/ https://ncbi.nlm.nih.gov/pubmed/32296512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2019-002093 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|